Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16372107 | 0.85 | KMT2A (0.35) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL20245054 | 0.85 | PDK2 (0.40) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL24064059 | 0.82 | ALDH1A1 (0.30) | — | |
| SCHEMBL20734798 | 0.80 | SMN1; SMN2 (0.41) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL24466275 | 0.80 | KDM4E (0.34) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL19225122 | 0.76 | KDM4E (0.34) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL20997731 | 0.75 | LMNA (0.33) | LMNA | |
| SCHEMBL30484151 | 0.75 | SMN1; SMN2 (0.52) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL29901176 | 0.75 | SMN1; SMN2 (0.52) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL15618159 | 0.75 | SMN1; SMN2 (0.52) | KDM4EMEN1LMNAMAPTOPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10916710-B2 | Heterocyclic compound and organic light-emitting element comprising same | LG CHEM, LTD. (KR) | 2021-02-09 | — | — | US | disclosed |
| US-20190051839-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2019-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10916710-B2 | Heterocyclic compound and organic light-emitting element comprising same | CRY1, CRY2, PER2 | KDM4E 2225/4885MEN1 822/4885LMNA 3136/4885 |
| US-20190051839-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | CRY1, CRY2, PER2 | KDM4E 2225/4885MEN1 822/4885LMNA 3136/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.